Product Code: ETC4746685 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
The Israel Influenza Vaccine Market is projected to witness mixed growth rate patterns during 2025 to 2029. Commencing at 10.66% in 2025, growth builds up to 11.11% by 2029.
By 2027, Israel's Influenza Vaccine market is forecasted to achieve a growing growth rate of 9.31%, with Germany leading the Europe region, followed by United Kingdom, France, Italy and Russia.
In Israel, the influenza vaccine market addresses public health needs by providing seasonal and pandemic influenza vaccines. Companies develop and distribute vaccines to prevent influenza infection, reducing the burden of illness and complications associated with seasonal flu outbreaks.
The Israel influenza vaccine market is experiencing robust growth driven by increasing awareness of the importance of vaccination in preventing seasonal influenza outbreaks and reducing healthcare burden. Influenza vaccines are essential for protecting individuals from influenza viruses by stimulating immune responses against viral strains prevalent in each flu season. Technological advancements in vaccine formulation, production methods, and delivery systems are driving market growth by improving vaccine efficacy, safety, and scalability. Moreover, the expansion of vaccination campaigns, government initiatives, and public health awareness programs is fueling market demand for influenza vaccines among all age groups, including high-risk populations such as the elderly and immunocompromised individuals. Additionally, the development of quadrivalent and adjuvanted influenza vaccines, along with advancements in vaccine storage and distribution infrastructure, is driving innovation in the influenza vaccine market, fostering market expansion and diversification.
Challenges in the influenza vaccine market include vaccine efficacy, production scalability, and distribution logistics. Innovations in vaccine development, manufacturing processes, and distribution networks are crucial for improving vaccine coverage and effectiveness in preventing seasonal and pandemic influenza outbreaks in Israel.
Israel promotes public health and disease prevention through supportive government policies in the influenza vaccine market. Initiatives focus on vaccination campaigns, procurement strategies, and regulatory frameworks to ensure accessibility, affordability, and effectiveness of influenza vaccines for the population.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Influenza Vaccine Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Influenza Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Influenza Vaccine Market - Industry Life Cycle |
3.4 Israel Influenza Vaccine Market - Porter's Five Forces |
3.5 Israel Influenza Vaccine Market Revenues & Volume Share, By Vaccine type, 2021 & 2031F |
3.6 Israel Influenza Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Israel Influenza Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Israel Influenza Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Israel Influenza Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Israel Influenza Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Influenza Vaccine Market Trends |
6 Israel Influenza Vaccine Market Segmentations |
6.1 Israel Influenza Vaccine Market, By Vaccine type |
6.1.1 Overview and Analysis |
6.1.2 Israel Influenza Vaccine Market Revenues & Volume, By Quadrivalent, 2021-2031F |
6.1.3 Israel Influenza Vaccine Market Revenues & Volume, By Trivalent, 2021-2031F |
6.2 Israel Influenza Vaccine Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Influenza Vaccine Market Revenues & Volume, By Seasonal, 2021-2031F |
6.2.3 Israel Influenza Vaccine Market Revenues & Volume, By Pandemic, 2021-2031F |
6.3 Israel Influenza Vaccine Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Israel Influenza Vaccine Market Revenues & Volume, By Egg-based, 2021-2031F |
6.3.3 Israel Influenza Vaccine Market Revenues & Volume, By Cell-based, 2021-2031F |
6.4 Israel Influenza Vaccine Market, By Age Group |
6.4.1 Overview and Analysis |
6.4.2 Israel Influenza Vaccine Market Revenues & Volume, By Pediatric, 2021-2031F |
6.4.3 Israel Influenza Vaccine Market Revenues & Volume, By Adult, 2021-2031F |
6.5 Israel Influenza Vaccine Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Israel Influenza Vaccine Market Revenues & Volume, By Injection, 2021-2031F |
6.5.3 Israel Influenza Vaccine Market Revenues & Volume, By Nasal Spray, 2021-2031F |
7 Israel Influenza Vaccine Market Import-Export Trade Statistics |
7.1 Israel Influenza Vaccine Market Export to Major Countries |
7.2 Israel Influenza Vaccine Market Imports from Major Countries |
8 Israel Influenza Vaccine Market Key Performance Indicators |
9 Israel Influenza Vaccine Market - Opportunity Assessment |
9.1 Israel Influenza Vaccine Market Opportunity Assessment, By Vaccine type, 2021 & 2031F |
9.2 Israel Influenza Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Israel Influenza Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Israel Influenza Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.5 Israel Influenza Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Israel Influenza Vaccine Market - Competitive Landscape |
10.1 Israel Influenza Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Israel Influenza Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |